antacid
- Generic Name
- antacid
A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 16
- Registration Number
- NCT05028673
- Locations
- 🇬🇧
LabCorp Clinical Research Unit Ltd, Leeds, United Kingdom
Human Cerebral Blood Flow Regulation
Early Phase 1
Recruiting
- Conditions
- Cerebral Arterial Diseases
- Interventions
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Wisconsin, Madison
- Target Recruit Count
- 111
- Registration Number
- NCT04265053
- Locations
- 🇺🇸
University of Wisconsin, Madison, Madison, Wisconsin, United States
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT02097329
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Effect of Antacids on the Pharmacokinetics of Raltegravir
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 17
- Registration Number
- NCT00944307
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath